MFP
GILD icon

Meramec Financial Planners’s Gilead Sciences GILD Stock Holding History

Meramec Financial Planners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29K Buy
41
+1
+3% +$132 ﹤0.01% 394
2026
Q1 		$5.47K Hold
40
– – ﹤0.01% 382
2025
Q4 		$6.1K Buy
+40
New +$4.86K ﹤0.01% 379

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meramec Financial Planners's GILD Position: Q2 2026 in Review

Meramec Financial Planners increased its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, buying an estimated $132 and bringing the position to 41 shares worth $5.29K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

Meramec Financial Planners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.1K in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meramec Financial Planners held 41 shares of Gilead Sciences worth $5.29K as of Q2 2026.
  • Meramec Financial Planners bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up ﹤0.01% of Meramec Financial Planners's portfolio in Q2 2026, its #394 holding.
  • Meramec Financial Planners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Meramec Financial Planners's Gilead Sciences position peaked at $6.1K in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.